Eagle Pharmaceuticals, which develops and sells enhanced injectable products, filed on Friday with the SEC to raise up to $50 million in an initial public offering. The Woodcliff Lake, NJ-based company, which was founded in 2007 and booked $14 million in sales for the fiscal year ended September 30, 2013, plans to list on the NASDAQ under the symbol EGRX.
Help employers find you! Check out all the jobs and post your resume.
